期刊文献+

复发性卵巢癌再次手术意义的探讨 被引量:1

Discussion on repeatoperation for recurrent ovarian carcinoma
下载PDF
导出
摘要 目的探讨复发性卵巢癌再次行肿瘤细胞减灭术的临床效果。方法对我院及北京大学肿瘤医院1990年1月至2004年2月收治的68例复发性卵巢癌再次手术患者的临床资料进行回顾性分析。结果68例再次手术中,无肉眼残留26例,残留<2cm者18例,残留>2cm者24例,带瘤生存10例,无瘤生存11例,死亡47例。中位生存期手术组与非手术组无显著性差异。结论对于复发性卵巢癌,有条件者应选择再次手术,可以改善患者的一般状况,提高生活质量。 Objective The patients with recurrent ovarian carcinoma are usually associated with very complicated conditions, very difficult to treat, and the survival rate is very low. This paper explores the final outcome of repeat operations and cytoreduction operation for these patients. Methods The clinical data of 68 patients with recurrent ovarian carcinoma from January 1990 to February 2004 in People's Hospital, Peking University and Cancer Hospital Peking University were retrospectively analyzed. Results Among 68 cases with repeat operation no residual tumors could be observed grossly in 26 cases, residual tumors 〈 2 cm in 18 cases and residual tumors 〉 2 cm in 24 casess. Eleven cases survived with residual tumors, while other 47 cases died. There was no difference between median survival time and repeat operation. Conduslons For the recurrent ovarian carcinoma, repeat operation can improve patients' general condition and their guality of life.
作者 吴燕 李蔚范
出处 《北京医学》 CAS 2007年第1期19-21,共3页 Beijing Medical Journal
关键词 卵巢肿瘤 复发 外科手术 Ovarian carcinoma Recurrent Operation
  • 相关文献

参考文献1

二级参考文献2

  • 1Sun T W,Chin Med J,1998年,111卷,272页
  • 2Eisenkop S M,Cancer,1995年,76卷,1606页

共引文献3

同被引文献13

  • 1麦劲壮,李河,方积乾,刘小清,饶栩栩.Meta分析中失安全系数的估计[J].循证医学,2006,6(5):297-300. 被引量:141
  • 2冯梅,陈桂林,李秀华,陈琴,郭慈仁.复发性卵巢上皮癌67例临床分析[J].福建医药杂志,2006,28(6):31-32. 被引量:2
  • 3Tebes SJ, Sayer RA, Palmer JM, et al. Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma[ J]. Gynecol Oncol, 2007,106 ( 3 ) ;482-487.
  • 4Salani R, Santillan A, Zahurak ML,et al. Secondary cytoreductive surgery for localized recurrent epithelial ovarian cancer: analysis of prognostic factors and survival outcome [ J ]. Cancer, 2007, 109(4) :685-691.
  • 5Panici B, De Vivo A, Bellati F, et al. Secondary cytoreductive surgery in patients with platinum- sensitive recurrent ovarian cancer[J]. Ann Surg Oncol, 2007, 14(3) :1136-1142.
  • 6Chi DS, McCaughty K, Diaz JP, et al. Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma [ J ]. Cancer, 2006, 106(9) :1933-1939.
  • 7Matsumoto A, Higuehi T, Yura S, et al. Role of salvage cytoreductive surgery in the treatment of patients with recurrent ovarian cancer after platinum-based chemotherapy [ J ]. J Obstet Gynecol, 2006, 32(6) :580-587.
  • 8Pfisterer J, Hatter P, Canzler U, et al. The role of surgery in recurrent ovarian cancer[ J]. Int J Gynecol Cancer, 2005, 15 ( Suppl 3 ) : 195-198.
  • 9Onda T, Yoshikawa H, Yasugi T, et al. Secondary cytoreductive surgery for recurrent epithelial ovarian carcinoma: proposal for patient selection [ J ]. Br J Cancer, 2005, 92 ( 6 ) : 1026- 1032.
  • 10Gronlund B, Lundvall L, Christensen IJ, et al. Surgical cytoreduction in recurrent ovarian carcinoma in patients with complete response to paclitaxel-platinum [ J ]. Eur J Surg Oncol, 2005, 31(1) :67-73.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部